4.5 Article

Potentiation of μ-opioid receptor-mediated signaling by ketamine

Related references

Note: Only part of the references are listed.
Review Psychiatry

Glutamatergic Modulators: The Future of Treating Mood Disorders?

Carlos Zarate et al.

HARVARD REVIEW OF PSYCHIATRY (2010)

Article Biochemistry & Molecular Biology

ERK phosphorylation: Spatial and temporal regulation by G protein-coupled receptors

Lauren T. May et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)

Article Multidisciplinary Sciences

Agonist-selective signaling is determined by the receptor location within the membrane domains

Hui Zheng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Multidisciplinary Sciences

Hemopressin is an inverse agonist of CB1 cannabinoid receptors

Andrea S. Heimann et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Neurosciences

Opioid receptor endocytosis and activation of MAP kinase pathway

N Trapaidze et al.

MOLECULAR BRAIN RESEARCH (2000)